Placebo response in trials of drug treatments for cancer-related fatigue: a systematic review, meta-analysis and meta-regression.

There is some evidence, based on trials with small samples, that the PR in trials testing drugs for CRF is non-trivial in size and statistically significant. We recommend that researchers planning drug studies in CRF should consider implementing alternative trial designs to better account for PR and decrease impact on the study results.